Vaccines

Vaccines groups companies working on preventive or therapeutic vaccine platforms across infectious disease, oncology, and public health. This sector page includes businesses developing traditional vaccines as well as newer platform approaches such as mRNA or recombinant protein vaccines.

Why watch Vaccines

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Vaccines news

The latest feed items from companies currently grouped under Vaccines.

1. 01
   2026-07-14 12:00 EST

   PMNProMIS Neurosciences Reports First Human Evidence of Amyloid-Beta Oligomer Target Engagement by PMN310 at AAIC 2026

   Source: ProMIS Neurosciences

2. 02
   2026-07-13 12:00 EST

   BAVNNews | Bavarian Nordic

   Source: Bavarian Nordic

3. 03
   2026-07-13 07:00 EST

   GSKJemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer

   Source: GSK plc

4. 04
   2026-07-10 19:01 EST

   MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC)

   Source: Merck

5. 05
   2026-07-10 11:00 EST

   GSKGSK’s licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population

   Source: GSK plc

6. 06
   2026-07-10 10:06 EST

   MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10) Advanced Triple-Negative Breast Cancer (TNBC) - Merck.com

   Source: Merck

7. 07
   2026-07-10 10:06 EST

   MRKMerck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV - Merck.com

   Source: Merck

8. 08
   2026-07-10 10:06 EST

   MRKMerck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 - Merck.com

   Source: Merck

9. 09
   2026-07-09 19:07 EST

   MRKGilead and Merck Announce Positive Topline Results from two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment - Merck.com

   Source: Merck

10. 10
    2026-07-09 12:00 EST

    NVAXNovavax Reports First Quarter 2026 Financial Results and Operational Highlights - May 6, 2026

    Source: Novavax

11. 11
    2026-07-09 12:00 EST

    NVAXNovavax to Participate in BofA Securities 2026 Health Care Conference - May 7, 2026

    Source: Novavax

12. 12
    2026-07-09 12:00 EST

    NVAXNovavax to Participate in 2026 Jefferies Global Healthcare Conference - Jun 1, 2026

    Source: Novavax

13. 13
    2026-07-09 11:56 EST

    MRKFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell Renal Cell Carcinoma (ccRCC) - Merck.com

    Source: Merck

14. 14
    2026-07-09 11:56 EST

    MRKU.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease - Merck.com

    Source: Merck

15. 15
    2026-07-09 11:56 EST

    MRKMerck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Merck.com

    Source: Merck

16. 16
    2026-07-09 11:56 EST

    MRKEuropean Commission Approves KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First PD-1 Inhibitor Plus Antibody-Drug Conjugate Regimen for Adults With Cisplatin-Ineligible Resectable Muscle-Invasive Bladder Cancer - Merck.com

    Source: Merck

17. 17
    2026-07-09 10:00 EST

    GLSIGreenwich LifeSciences Announces European Approval for Use of Commercially Manufactured GP2 in FLAMINGO-01

    Source: Greenwich LifeSciences

18. 18
    2026-07-09 10:00 EST

    GSKRoy Jakobs to join GSK Board as Non-Executive Director

    Source: GSK plc

19. 19
    2026-07-09 03:04 EST

    GRNAGreenLight Biosciences 2026

    Source: GreenLight Biosciences

20. 20
    2026-07-09 03:04 EST

    GRNAGreenLight Biosciences 2026

    Source: GreenLight Biosciences

Companies in Vaccines

28 companies tagged with Vaccines.

Frequently Asked Questions